March 12, 2017
- Now Recruiting Research Participants
- Research Team
- Research Partners
- OICC Research
- Evidence-Based Monographs
- Conference Presentations
Changing how we live with cancerDonate Today!
29 Bayswater Avenue
Ottawa, Ontario K1Y 2E5View Location Map
The OICC gratefully acknowledges support of our research funders.
Canadian Complementary and Alternative Medicine Research Fund
The primary goal of the Canadian Complementary and Alternative Medicine Research Fund is to increase and enhance complementary medicine research capacity in Canada by supporting and funding relevant and high caliber studies. Funding through the CCRF is being used to support two studies: 1) Towards Integrative Cancer Care: A Participatory, Formative Evaluation of Practitioner Integration at the Ottawa Integrative Cancer Centre; and 2) An n-of-1 study of homeopathic treatment of fatigue in patients receiving chemotherapy.
Canadian Institutes of Health Research
The Canadian Institutes of Health Research (CIHR) is the Government of Canada’s premier agency for health research. Funding through the CIHR is being used to support OICC efforts towards: Developing a Community-Based Integrative Oncology Research Program. CIHR funding has also helped support two large scale synthesis reviews on natural health products used by people with lung and breast cancer respectively.
Gateway for Cancer Research
Since their beginnings nearly 20 years ago, the Gateway for Cancer Research has sought better treatment options for cancer patients—options that extend life, improve quality of life, and strive to cure people. Funding through The Gateway for Cancer Research is being used to support the study: Adjuvant Melatonin in the Prevention of Recurrence and Mortality Following Lung Cancer Resection: A Phase II Substudy of a Randomized Placebo Controlled Clinical Trial.
Lotte and John Hecht Memorial Foundation
One of the Lotte and John Hecht Memorial Foundation’s two major objectives is to support the investigation and support of complementary and alternative medicine, particularly in the treatment of cancer. Funding through the Lotte and John Hecht Memorial Foundation supports the ongoing operations of the OICC, and Foundation support also made the multi-phase feasibility study that informed the development of the OICC model possible and is the principal supporter of the multi-site Canadian trial run led by Dr. Seely, the Adjuvant Melatonin in the Prevention of Recurrence and Mortality Following Lung Cancer Resection: A Randomized Placebo Controlled Clinical Trial (AMPLCaRe).
Ottawa Regional Cancer Foundation
The Ottawa Regional Cancer Foundation supports research and cancer care, to prevent, detect, diagnose and cure cancer. Funding through the Ottawa Regional Cancer Foundation supports our clinical research into the safety and effectiveness of intravenous vitamin C, including:
- A 1-year Prospective Cohort Study on the impact of Intravenous Vitamin C on Quality of Life for People living with Breast, Lung, Pancreatic and Ovarian Cancer.
- A 5-year Prospective Cohort Study on the impact of Complementary Medicine Use on 5-year Survival and Recurrence for People living with Breast, Lung, Pancreatic and Ovarian Cancer.
- In addition to this large scale prospective study we are working with the ORCF to develop a tightly controlled randomized trial to explore the effect of Intravenous Vitamin C for people with non-small cell lung cancer.
Voices of Support
“I applaud the OICC’s commitment to being a leader in integrative oncology research. From interactions with mutual patients, I realize that the clinical care provided by the OICC has real value to the people under our care, and that this care can and should be expanded to others. With the research that we’ve done together already and the approach you take in science and clinical care, I believe the OICC will achieve great prominence as a valuable resource for patients.”
Latest Blog Posts
March 12, 2017